CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −2,955 | $78.09 | $231K | 96,277 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −452 | $78.66 | $36K | 95,825 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −1,200 | $75.93 | $91K | 94,625 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −1,750 | $76.96 | $135K | 92,875 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −2,720 | $77.92 | $212K | 90,155 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −1,088 | $78.68 | $86K | 89,067 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −240 | $75.88 | $18K | 88,827 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −360 | $77.06 | $28K | 88,467 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −438 | $78.14 | $34K | 88,029 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −48 | $78.96 | $4K | 87,981 |
| 2022-08-03 | Benaim Ely Chief Medical Officer | Sale | −563 | $71.09 | $40K | 34,068 |
| 2022-08-03 | Benaim Ely Chief Medical Officer | Sale | −5,396 | $74.00 | $399K | 28,672 |
| 2022-08-02 | Cordova Ashley Chief Financial Officer | Grant or award | +7,122 | $70.20 | $500K | 73,261 |
| 2022-08-02 | DOYLE WILLIAM F Executive Chairman | Sale | −837 | $69.66 | $58K | 551,176 |
| 2022-08-02 | Benaim Ely Chief Medical Officer | Sale | −437 | $69.66 | $30K | 34,631 |
| 2022-08-02 | Leonard Frank X Chief Development Officer | Sale | −414 | $69.66 | $29K | 102,193 |
| 2022-07-05 | Weinberg Uri Chief Science Officer | Grant or award | +281 | $59.08 | $17K | 49,483 |
| 2022-07-05 | Ben Arye Barak General Counsel | Grant or award | +144 | $59.08 | $9K | 17,002 |
| 2022-07-05 | Cordova Ashley Chief Financial Officer | Grant or award | +251 | $59.08 | $15K | 66,139 |
Page 20 of 20 · 399 trades